Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.

@article{Noticewala2017LongitudinalCI,
  title={Longitudinal Changes in Active Bone Marrow for Cervical Cancer Patients Treated With Concurrent Chemoradiation Therapy.},
  author={Sonal S Noticewala and Nan Li and Casey W. Williamson and Carl K. Hoh and Hanjie Shen and Michael McHale and Cheryl C. Saenz and J. P. Einck and Steven C. Plaxe and Florin Vaida and Catheryn M. Yashar and Loren K. Mell},
  journal={International journal of radiation oncology, biology, physics},
  year={2017},
  volume={97 4},
  pages={
          797-805
        }
}
PURPOSE To quantify longitudinal changes in active bone marrow (ABM) distributions within unirradiated (extrapelvic) and irradiated (pelvic) bone marrow (BM) in cervical cancer patients treated with concurrent chemoradiation therapy (CRT). METHODS AND MATERIALS We sampled 39 cervical cancer patients treated with CRT, of whom 25 were treated with concurrent cisplatin (40 mg/m2) and 14 were treated with cisplatin (40 mg/m2) plus gemcitabine (50-125 mg/m2) (C/G). Patients underwent 18F… CONTINUE READING